Meridiem Capital Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Buy
+316,950
New +$6M 0.36% 61
2025
Q3
Sell
-123,390
Closed -$2.41M 75
2025
Q2
$2.41M Buy
+123,390
New +$2.19M 0.17% 68

Other funds holding CDNA

Meridiem Capital Partners's CDNA Position: Q1 2026 in Review

Meridiem Capital Partners opened a new position in CareDx (CDNA) in Q1 2026: 316,950 shares worth $5.5M. The stake represents 0.36% of the portfolio and ranks #61 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in CDNA as recently as Q2 2025.

Meridiem Capital Partners first reported a position in CDNA in Q2 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Meridiem Capital Partners held 316,950 shares of CareDx worth $5.5M as of Q1 2026.
  • CareDx was a new Meridiem Capital Partners position in Q1 2026.
  • CareDx made up 0.36% of Meridiem Capital Partners's portfolio in Q1 2026, its #61 holding.
  • Meridiem Capital Partners first reported a position in CareDx in Q2 2025 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Meridiem Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.